Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm

Clinical trial NCT06195241 · RECRUITING

Trial details

NCT number: NCT06195241
Sponsor: Montefiore Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Benign Essential Blepharospasm Hemifacial Spasm

Start date: 2025-02-11
Primary completion: 2027-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.